149
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Design, synthesis, and preliminary biological evaluation of chrysin amino acid derivatives that induce apoptosis and suppress cell migration

, , , &
Pages 547-561 | Received 21 Dec 2018, Accepted 11 Mar 2019, Published online: 02 Apr 2019
 

Abstract

Amino acid derivatives containing chrysin were synthesized for evaluating their anticancer effects. Among them, compound N-(7-((5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)heptanoyl)-L-isoleucine (6e) displayed the most potent antiproliferative activity against MGC-803 cells with IC50 value of 20.0 μM. Preliminary mechanistic studies showed that compound 6e could inhibit the colony formation and migration of MGC-803 cells. Flow cytometry analysis demonstrated that compound 6e mediated cell apoptosis of MGC-803 cells and arrested cell cycle in G2/M-phase. Moreover, 6e treatment in MGC-803 cells downregulated anti-apoptotic protein Bcl-2 and upregulated pro-apoptotic gene Bax in a concentration-dependent manner. Our studies suggest that compound 6e may sever as an effective chemotherapeutic candidate.

Acknowledgements

Our deepest gratitude goes first and foremost to Professor Amy Schwarber and Doctor Yuhua Wang from Cincinnati children hospital and medicine center for their proofreading work.

Disclosure statement

The authors declare that there are no conflicts of interest.

Additional information

Funding

We are grateful to the Hunan Natural Science Foundation (2018JJ2349) and the University of South China Students Research Learning and Innovative Experimental Project (2018147200) for financial support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.